Trasylol
Sort by:
- Vioxx and TrasylolAmericas Watchdog and US Drug Watchdog are investigating Vioxx and Trasylol use when less riskier and inexpensive alternative drugs were available.
- The Ralph Nader of Cardiac Surgery Blows the Whistle on a Dangerous DrugDr. Daniel T. Mangano blows the whistle on what appears to be a crass case of a drug company (Bayer) placing profit over patient health.
- FDA Calls for the Recall of Trasylol in the Health MarketTrasylol is being pulled out of the health marketplace because of the risks to patients.
- Bayer Stops Sale of Trasylol, a Heart Bypass DrugThe pharmaceutical company Bayer has stopped selling and marketing Trasylol, also known as aprotinin, after studies indicated it increases the risk of death through hemorrhage.
- FDA Indicates Trasylol May Increase Death RiskThe Food and Drug Administration (FDA) says that a heart bypass drug marketed as Trasylol, also known as aprotinin, may increase the risk of death. The drug is used during heart bypass surgery to prevent major bleeding.
- Cardiac Bypass Surgery; A Guide to the Use and Side Effects of TrasylolWhen discussing cardiac bypass surgery planning with your surgeon, discuss the implications and use of Trasylol in the prevention of significant blood loss.